Treatment of ischemia reperfusion injury and treatment of cellular dysfunction including arrhythmia and heart failure subsequent to myocardial infarction

Details for Australian Patent Application No. 2007202621 (hide)

Owner Medicure Inc. University of Manitoba

Inventors Sethi, Rajat; Dhalla, Naranjan S; Dakshinamurti, Krishnamurti

Agent Griffith Hack

Pub. Number AU-A-2007202621

Priority 09112277 09.07.98 US

Filing date 6 June 2007

Wipo publication date 28 June 2007

International Classifications

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 31/4415 (2006.01) - Pyridoxine, i.e.vitamin B

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

28 June 2007 Application Open to Public Inspection

  Published as AU-A-2007202621

28 June 2007 Complete Application Filed

  Priority application(s): 09112277 09.07.98 US

27 September 2007 Standard Patent Sealed

23 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007202622-Method of generating power from naturally occurring heat without fuels and motors using the same

2007202620-Gaming machine